Provexis plantain medical food

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

GDen
Veteran Member


Date Joined May 2009
Total Posts : 703
   Posted 8/11/2009 9:19 PM (GMT -7)   
This just popped up on my radar screen. Never heard of it.
Somebody said...
Provexis kicks-off Crohn's Disease clinical trial
11 August 2009

Provexis, the life-science business, is about to kick-off a clinical trial for its NSP#3G plantain medical food for Crohn’s disease patients. A two-centre trial on Crohn’s disease patients in remission will commence on 18 August 2009. The trial will last for approximately 18 months, with 72 patients taking part.

Crohn’s disease is an inflammatory disease of the gastrointestinal tract causing a wide variety of symptoms. It affects between 400,000 and 600,000 in North America and estimates of incidence in Northern Europe range from 27 to 48 per 100,000 people. There is no known pharmaceutical or surgical cure for Crohn’s disease and treatment is restricted to controlling symptoms, maintaining remission and preventing relapse.

Stephen Moon, Chief Executive Officer of Provexis plc, commented:

'Our new technology addresses an important patient need for a debilitating disease where no effective medical food products for maintaining remission are available currently. Laboratory and human trial work to date has been very promising and we look forward to successful clinical data from this important trial.'

www.smallcapnews.co.uk/article/Provexis_kicksoff_Crohns_Disease_clinical_trial/8189.aspx
Somebody said...
Provexis to launch trial of NSP#3G plantain medical food in patients with Crohn's disease

Published in M2Europharma on Tuesday, 11 August 2009 at 15:31 GMT

11 August 2009 - Provexis plc (AIM: PXS), developing scientifically proven functional food, medical food and dietary supplement technologies, announced today the initiation of a clinical trial for its NSP#3G plantain medical food for Crohn's disease patients.

The results announcement of 9 June 2009 updated the Clinical Trials Authorisation received from the Medicines & Healthcare products Regulatory Agency. Provexis has since successfully completed the necessary pre-trial processes and can now announce a two-centre trial on Crohn's disease patients in remission will commence on 18 August 2009. The trial will run for approximately 18 months, with 72 patients taking part.

Crohn's disease is an inflammatory disease of the gastrointestinal tract causing a wide variety of symptoms. It affects between 400,000 and 600,000 in North America and estimates of incidence in Northern Europe range from 27 to 48 per 100,000 people. There is no known pharmaceutical or surgical cure for Crohn's disease and treatment is restricted to controlling symptoms, maintaining remission and preventing relapse. Provexis believes that its medical food technology will successfully maintain remission. The market for Crohn's disease treatments is estimated at USD1.7bn (EUR1.203bn) annually.

With the trial now starting and combined with recently obtained healthy human data, Provexis will start looking for potential global license or co-development partners to address this substantial market opportunity.

Stephen Moon, Provexis CEO, said that following the company's recent industry-first European Article 13(5) health claim

approval for its Fruitflow anti-thrombotic technology, this further underpins Provexis' capability in developing high quality and scientifically-proven intellectual property. The new technology addresses an important patient need for a debilitating disease where no effective medical food products for maintaining remission are available currently. Laboratory and human trial work to date has been very promising and Provexis looks forward to successful clinical data from this important trial, Moon explained.

www.m2.com/m2/web/story.php/200995510DD5A09DF8218025760F004F6B54

www.provexis.com/

CrohnsPatient
Regular Member


Date Joined Feb 2008
Total Posts : 314
   Posted 8/12/2009 4:33 AM (GMT -7)   
I've never heard of this and dont really know how to comment, didnt even have a chance to read the articles I just happened to notice that the part you pasted said 'Provexis has since successfully completed the necessary pre-trial processes and can now announce a two-centre trial on Crohn's disease patients in remission will commence on 18 August 2009' How are they going to know how well it helps if your in remission already? And doesnt that exclude more severe forms of it, meaning what about the people that rarely maintain or get to remission? What if they start a flare DURING The trial? I'd be interested in learning how they will deal with issues like that. Every little bit helps us, when it comes to new clinical trials and research.

ivy6
Elite Member


Date Joined Sep 2005
Total Posts : 10404
   Posted 8/12/2009 4:36 AM (GMT -7)   
I've heard of it - publicity / development started at least approx. five years ago, so it's nice to hear that it's in trial at last.
Co-Moderator Crohn's Forum.

Medications for Crohn's ~~ Diet and Nutritional Therapy for Crohn's ~~ Dealing with Abscesses and Fistulae ~~

New Topic Post Reply Printable Version
Forum Information
Currently it is Saturday, December 03, 2016 9:00 PM (GMT -7)
There are a total of 2,732,388 posts in 301,013 threads.
View Active Threads


Who's Online
This forum has 151175 registered members. Please welcome our newest member, melissapsa.
230 Guest(s), 11 Registered Member(s) are currently online.  Details
PeteZa, desert bound, Ides, compiler, Scaredy Cat, mpost, mbisoux, Hawaii3654, BostonMarigold, Kmuth, Mister Mike


Follow HealingWell.com on Facebook  Follow HealingWell.com on Twitter  Follow HealingWell.com on Pinterest
Advertisement
Advertisement

©1996-2016 HealingWell.com LLC  All rights reserved.

Advertise | Privacy Policy & Disclaimer